Mutagenesis induced by targeted alpha therapy using 213Bi-cDTPA- 9.2.27 in lacZ transgenic mice

Cancer Biology and Therapy

Volumn 8, Issue 9, 2009, Pages 777-781

  Allen, Barry J ^a,c   So, Trina ^b   Abbas Rizvi, Syed M ^a   Song, Emma Y ^a   Fernandez, Harvey R ^b   Lutz Mann, Louise ^b  

^a ST GEORGE HOSPITAL   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Absorbed dose; lacZ transgenic mice; Mutagenesis; Secondary cancer; Targeted alpha therapy

Indexed keywords

BETA GALACTOSIDASE; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 9.2.27; PENTETATE BISMUTH BI 213; PROTEIN P53; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER IMMUNOLOGY; CANCER RADIOTHERAPY; CONTROLLED STUDY; DNA DAMAGE; DRUG ABSORPTION; DRUG DISTRIBUTION; GENE MUTATION; HISTOPATHOLOGY; IN VIVO STUDY; MELANOMA; MOUSE; MUTAGENICITY; NONHUMAN; RADIATION DOSE; RADIATION MUTAGENESIS; TRANSGENIC MOUSE;

EID: 68149132396     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.8.9.8110     Document Type: Article

References (20)

1. Allen BJ. Can alpha-immunotherapy succeed where other systemic modalities have failed? Nucl Med Communications 1999; 20:205-7.
2. Allen BJ, Raja C, Rizvi S, Li Y, Tsui W, Zhang S, et al. Targeted alpha therapy for cancer. Phys Med Biol 2004; 49:3703-12.
3. Jurcic JG, Larson SM, Sgouros G, McDevitt MR, Finn RD, Divgi CR. Targeted alphaparticle immunotherapy for myeloid leukaemia. Blood 2002; 100:1233-9.
4. Allen BJ, Raja C, Rizvi SMA, Li Y, Tsui W, Graham P, et al. Intralesional targeted alpha therapy for metastatic melanoma. Cancer Biol Ther 2005; 4:1318-24.
5. Raja C, Graham P, Rizvi SMA, Song E, Goldsmith H, Thompson J, et al. Interim analysis of toxicity and response in Phase 1 trial of systemic targeted alpha therapy for metastatic melanoma. Cancer Biol Ther 2007; 6:846-52.
6. Allen BJ. Clinical trials of targeted alpha therapy for cancer. Rev Recent Clin Trials 2008; 3:185-91.
7. Zalutsky MR. Current status of therapy of solid tumours: brain tumour therapy. J Nucl Med 2005; 46:151-6.
8. th Alpha-Immunotherapy Symposium. Morgenstern A, Ed. ITU: Dusseldorf, Germany 2004; 12.
9. Nilsson S, Larsen RH, Fosså SD, Balteskard L, Borch KW, Westlin JE, et al. First clinical experience with alpha-emitting radium-223 in the treatment of skeletal metastases. Clin Cancer Res 2005; 11:4451-9.
10. Allen BJ, Raja C, Rizvi SMA, Song EY, Graham P. Tumour anti-vascular alpha therapy: a mechanism for the regression of solid tumours in metastatic cancer. Phys Med Biol 2007; 52:15-9.
11. Borak TB. Quality factors for alpha particles emitted in tissue. Health Phys 2002; 82:102-4.
12. Chang PY, Kanazawa N, Lutze-Mann L, Winegar RA. p53 deficiency alters the yield and spectrum of radiation-induced lacZ mutants in the brain of transgenic mice. Mutagenesis 2001; 16:7-17.
13. Allen BJ, Rizvi SMA and Tian Z. Preclinical targeted alpha therapy for subcutaneous melanoma. Melanoma Res 2001; 11:1-8.
14. Rizvi SMA, Qu CF, Song YJ, Raja C, Allen BJ. In vivo studies and efficacy of Bi-213 labeled anti-melanoma monoclonal antibody 9.2.27. Cancer Biol Ther 2005; 4:763-8.
15. Rizvi SMA, Sarkar S, Goozee G, Allen BJ. Radioimmunoconjugates for targeted alpha therapy of malignant melanoma. Melanoma Res 2000; 10:281-9.
16. Loevinger R, Berman M. A schema for absorbed dose calcualtions for biological distributed radionuclides. J Nucl Med 1968; 9:7-9.
17. Gossen JA, de Leeuw WJ, Douglas GR, Vijg J. Plasmid rescue from transgenic muse DNA using lacI repressor protein conjugated to magnetic beads. Biotechniques 1993; 14:624-9.
18. So T. Mutagenesis induced by radioimmunotherapy in transgenic mice. MSc Thesis, School of Biochemistry and Molecular Genetics, University NSW 2001.
19. th Edition Garland Science NY 2007.
20. Boerrigter M. Treatment of lacZ plasmid-based transgenic mice with benzo[a]pyrene: measurement of DNA adduct levels, mutant frequencies and mutant spectra. Environ Mol Mutagensis 1999; 34:140-7.